Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

BACKGROUND: The aim of this study was to assess the cost-effectiveness of administering magnesium sulphate to patients in whom preterm birth at < 32(+0) weeks gestation is either imminent or threatened for the purpose of fetal neuroprotection. METHODS: Multiple decision tree models and probabilis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bickford, Celeste D, Magee, Laura A, Mitton, Craig, Kruse, Marie, Synnes, Anne R, Sawchuck, Diane, Basso, Melanie, Senikas, Vyta M, von Dadelszen, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878233/
https://ncbi.nlm.nih.gov/pubmed/24350635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-13-527
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados